Director/PDMR Shareholding

28 Mar 2008 11:52

IQE PLC28 March 2008 IQE plc28 March 2008 IQE plc ('IQE' or the 'Company') DIRECTORS' DEALINGS Dr Godfrey Ainsworth, Non-Executive Chairman of IQE, has previously reported abeneficial interest in 2,502,621 shares held in the name of Gambit CorporateFinance of which he is a partner. On 27 March 2008 he notified the Company thathe has become the sole beneficiary of 819,271 of these "Gambit" shares and otherequity partners in Gambit will become the sole beneficiaries of the remainingGambit holding. This change allows individual partners to put in to effectpersonal tax planning measures and is as a consequence of the changes in UKCapital Gains Tax to be implemented on 6th April 2008. The transferees havegiven an undertaking that they will not, otherwise to effect tax planning, sellor transfer their beneficial interest in these shares for a period of 12 monthsfrom the date of this announcement. Consequently Dr Ainsworth now has a sole beneficial interest in 2,605,570 sharesrepresenting 0.6% of the issued share capital of the Company, being 431,043,197ordinary shares of 1p each. Contacts: IQE plc +44 29 2083 9400Drew NelsonPhil RasmussenChris Meadows College Hill +44 20 7457 2020Adrian Duffield/Ben Way Noble & Company Limited +44 20 7763 2200John Llewellyn-Lloyd/ Sam Reynolds Panmure Gordon (UK) Limited +44 20 7459 3600Aubrey Powell/ Ashton Clanfield NOTE TO EDITORS IQE plc is the leading global supplier of advanced semiconductor wafers withproducts that cover a diverse range of applications. It is able to provide a'one stop shop' for the wafer needs of the world's leading compoundsemiconductor manufacturers, who in turn use these wafers to make the chipswhich form the key components of virtually every high technology system. IQE hasparticular focus on the growing global wireless sector for applicationsincluding; mobile handsets, wireless infrastructure, Wi-Fi, WiMAX, basestations, GPS and satellite communications; as well as for the opticalcommunication sector including; optical storage (CD, DVD), laser optical mice,laser printers & photocopiers, thermal imagers, leading-edge medical products,bar-coding, high efficiency LEDs and advanced solar cells. The manufacturers of these chips are increasingly seeking to outsource waferproduction to specialist foundries such as IQE in order to reduce overall wafercosts and accelerate time to market. IQE is unique in being able to supplywafers using all of the leading crystal growth technology platforms includingMetal Organic Vapour Phase Epitaxy (MOVPE) and Molecular Beam Epitaxy (MBE) andthe Group is able to leverage its global purchasing volumes to reduce the costof raw materials. IQE also provides bespoke R&D services to deliver customized materials forspecific applications and offers specialist technical staff to manufacture tospecification either at its own facilities or on the customer's own sites. Thisis backed by a strategy of duplicating each key product processes over multiplesites to assure customers of security of supply as well as provide compellingcustomer benefits in terms of flexibility and predictability of cost, therebysignificantly reducing operating risk. IQE operates six manufacturing facilities; two in Cardiff and one in MiltonKeynes in the UK; two more in Bethlehem, Pennsylvania and Somerset, New Jerseyin the USA; and its most recent acquisition in Singapore. The Group also has 11sales offices located in major economic centres worldwide. This information is provided by RNS The company news service from the London Stock Exchange